Out of 381 AML patients who met our criteria, 31 had IDH2 mutations, including 23 with R140 (74%) and 8 with R172 (26%), and 8 had IDH1 mutations (all R132). This evidence concerns the gene IDH2 and acute myeloid leukemia.